Home LiteratureArticle Details
PMID: 9159149 Published · ppublish English Comparative Study Journal Article Research Support, Non-U.S. Gov't

In the absence of the invariant chain, HLA-DR molecules display a distinct array of peptides which is influenced by the presence or absence of HLA-DM.

Lightstone L, Hargreaves R, Bobek G, Peterson M, Aichinger G, Lombardi G, Lechler R

Abstract

The independent influences of invariant chain (Ii) and HLA-DM molecules on the array of naturally processed peptides displayed by HLA-DR molecules were studied using transfected cell lines. The absence of Ii led to an altered set of HLA-DR-bound peptides as judged by the discriminating responses of alloreactive T cell clones. While most T cell clones raised against DR+Ii+DM+ peripheral blood mononuclear cells (PBMC) failed to respond to DR+Ii-DM- cells, T cell clones raised against DR+Ii-DM- transfectants were not stimulated by DR+Ii+DM+ cells. Furthermore, coexpression of HLA-DM with HLA-DR1 in the absence of Ii augmented responses of anti-PBMC T cell clones but inhibited allorecognition by T cell clones raised against DR+Ii-DM- transfectants. The conformational integrity of the class II molecules, as judged by serology, suggests that the patterns of reactivity of the T cell clones reflect specificity for different alloantigen-bound peptides. Hence, discordant regulation of expression of major histocompatibility complex class II, Ii, and HLA-DM molecules in vivo may lead to the display of novel self-peptides and possible interruption of self-tolerance.

MeSH Terms
Antigen-Presenting Cells/immunology Antigens, CD/biosynthesis Antigens, Differentiation, B-Lymphocyte/biosynthesis Cell Line Epitopes/analysis HLA-D Antigens/biosynthesis,immunology HLA-DR Antigens/biosynthesis,chemistry Histocompatibility Antigens Class II/biosynthesis Humans Kinetics Protein Conformation Recombinant Proteins/biosynthesis,chemistry T-Lymphocytes/immunology Transfection
Chemicals
Antigens, CD Antigens, Differentiation, B-Lymphocyte Epitopes H2-M antigens HLA-D Antigens HLA-DM antigens HLA-DR Antigens Histocompatibility Antigens Class II Recombinant Proteins invariant chain
Authors & Affiliations
7 authors, click to expand affiliations / ORCID
Lightstone L
Department of Immunology, Commonwealth Building, Royal Postgraduate Medical School, Du Cane Road, London, W12 0NN, England. [email protected]
Hargreaves R
Bobek G
Peterson M
Aichinger G
Lombardi G
Lechler R
References (41)
41 references, click to expand
  1. Two populations of Ia-like molecules on a human B cell line.
    J Immunol. 1980 Jul;125(1):293-9 PMID: 6966655
  2. The structure of an intermediate in class II MHC maturation: CLIP bound to HLA-DR3.
    Nature. 1995 Nov 30;378(6556):457-62 PMID: 7477400
  3. A human Ia cytoplasmic determinant located on multiple forms of invariant chain (gamma, gamma 2, gamma 3).
    J Immunol. 1984 Apr;132(4):1900-5 PMID: 6199417
  4. Biological and biochemical characterization of an SV40-transformed xeroderma pigmentosum cell line.
    Exp Cell Res. 1984 Apr;151(2):408-20 PMID: 6323201
  5. The primary alloresponse of human CD4+ T cells is dependent on B7 (CD80), augmented by CD58, but relatively uninfluenced by CD54 expression.
    Int Immunol. 1995 Sep;7(9):1505-13 PMID: 7495758
  6. Truncation of the class II beta-chain cytoplasmic domain influences the level of class II/invariant chain-derived peptide complexes.
    Proc Natl Acad Sci U S A. 1996 Jan 9;93(1):241-4 PMID: 8552613
  7. Association between HLA-DM and HLA-DR in vivo.
    Immunity. 1996 Jan;4(1):87-96 PMID: 8574855
  8. Invariant chain protects class II histocompatibility antigens from binding intact polypeptides in the endoplasmic reticulum.
    EMBO J. 1996 Jan 15;15(2):418-28 PMID: 8617217
  9. The repertoire of T cells shaped by a single MHC/peptide ligand.
    Cell. 1996 Feb 23;84(4):521-9 PMID: 8598039
  10. Binding domain regulation of MHC class II molecule assembly, trafficking, fate, and function.
    Semin Immunol. 1995 Dec;7(6):361-72 PMID: 8775462
  11. Invariant chain and DM edit self-peptide presentation by major histocompatibility complex (MHC) class II molecules.
    J Exp Med. 1996 Nov 1;184(5):1747-53 PMID: 8920863
  12. HLA class II regulation and structure. Analysis with HLA-DR3 and HLA-DP point mutants.
    J Exp Med. 1985 Oct 1;162(4):1193-207 PMID: 2413154
  13. Efficient cell surface expression of class II MHC molecules in the absence of associated invariant chain.
    J Exp Med. 1986 Nov 1;164(5):1478-89 PMID: 3464691
  14. Synthesis and expression of MHC class II molecules in the absence of attached invariant chains by recombinant-interferon-gamma-activated bone-marrow-derived macrophages.
    Eur J Immunol. 1987 Sep;17(9):1235-42 PMID: 3115789
  15. Co-recognition of endogenous antigens with HLA-DR1 by alloreactive human T cell clones.
    J Immunol. 1989 Feb 1;142(3):753-9 PMID: 2492329
  16. The molecular basis of alloreactivity.
    Immunol Today. 1990 Mar;11(3):83-8 PMID: 2186745
  17. A gene required for class II-restricted antigen presentation maps to the major histocompatibility complex.
    J Exp Med. 1991 Dec 1;174(6):1607-15 PMID: 1744588
  18. The antigen-processing mutant T2 suggests a role for MHC-linked genes in class II antigen presentation.
    J Immunol. 1992 Apr 15;148(8):2586-90 PMID: 1373173
  19. HLA-DR associates with specific stress proteins and is retained in the endoplasmic reticulum in invariant chain negative cells.
    J Exp Med. 1992 Sep 1;176(3):657-66 PMID: 1512535
  20. HLA-DR molecules from an antigen-processing mutant cell line are associated with invariant chain peptides.
    Nature. 1992 Dec 3;360(6403):474-7 PMID: 1448172
  21. Characterization of endogenous peptides bound to purified HLA-DR molecules and their absence from invariant chain-associated alpha beta dimers.
    J Immunol. 1993 Jan 15;150(2):499-507 PMID: 8419482
  22. Relationship between invariant chain expression and major histocompatibility complex class II transport into early and late endocytic compartments.
    J Exp Med. 1993 Mar 1;177(3):583-96 PMID: 8436902
  23. Mice lacking the MHC class II-associated invariant chain.
    Cell. 1993 Feb 26;72(4):635-48 PMID: 7679955
  24. Defective major histocompatibility complex class II assembly, transport, peptide acquisition, and CD4+ T cell selection in mice lacking invariant chain expression.
    J Exp Med. 1993 Jun 1;177(6):1699-712 PMID: 8098731
  25. Intracellular distribution of the MHC class II molecules and the associated invariant chain (Ii) in different cell lines.
    Int Immunol. 1993 Aug;5(8):903-17 PMID: 8398985
  26. Unexpected lack of reactivity of allogeneic anti-Ia monoclonal antibodies with MHC class II molecules expressed by mouse intestinal epithelial cells.
    J Immunol. 1993 Nov 1;151(9):4642-50 PMID: 8409425
  27. Diversity of endogenous epitopes bound to MHC class II molecules limited by invariant chain.
    Science. 1994 Mar 4;263(5151):1284-6 PMID: 7510069
  28. An essential role for HLA-DM in antigen presentation by class II major histocompatibility molecules.
    Nature. 1994 Apr 7;368(6471):551-4 PMID: 8139689
  29. HLA-DMA and -DMB genes are both required for MHC class II/peptide complex formation in antigen-presenting cells.
    Nature. 1994 Apr 7;368(6471):554-8 PMID: 8139690
  30. An N-terminal double-arginine motif maintains type II membrane proteins in the endoplasmic reticulum.
    EMBO J. 1994 Apr 1;13(7):1696-705 PMID: 8157008
  31. Assembly of HLA DR1 molecules translated in vitro: binding of peptide in the endoplasmic reticulum precludes association with invariant chain.
    EMBO J. 1994 Jun 1;13(11):2699-707 PMID: 8013468
  32. The invariant chain inhibits presentation of endogenous antigens by a human fibroblast cell line.
    Eur J Immunol. 1994 Jul;24(7):1632-9 PMID: 8026524
  33. Supermotifs enable natural invariant chain-derived peptides to interact with many major histocompatibility complex-class II molecules.
    J Exp Med. 1995 Feb 1;181(2):527-36 PMID: 7836909
  34. Binding of major histocompatibility complex class II to the invariant chain-derived peptide, CLIP, is regulated by allelic polymorphism in class II.
    J Exp Med. 1995 Feb 1;181(2):677-83 PMID: 7836921
  35. Poor loading of major histocompatibility complex class II molecules with endogenously synthesized short peptides in the absence of invariant chain.
    Eur J Immunol. 1995 Jan;25(1):48-53 PMID: 7843252
  36. Biased TCR gene usage in alloreactive T cells specific for a structurally dissimilar MHC alloantigen.
    Int Immunol. 1994 Nov;6(11):1785-90 PMID: 7865471
  37. In vivo and in vitro formation and dissociation of HLA-DR complexes with invariant chain-derived peptides.
    Immunity. 1994 Dec;1(9):763-74 PMID: 7895165
  38. Assembly and intracellular transport of HLA-DM and correction of the class II antigen-processing defect in T2 cells.
    Immunity. 1994 Oct;1(7):595-606 PMID: 7600288
  39. HLA-DM induces CLIP dissociation from MHC class II alpha beta dimers and facilitates peptide loading.
    Cell. 1995 Jul 14;82(1):155-65 PMID: 7606781
  40. Endosomal localization of MHC class II-invariant chain complexes.
    Immunol Res. 1994;13(4):244-52 PMID: 7616052
  41. Direct demonstration of an HLA-DR allotypic determinant on the low molecular weight (beta) subunit using a mouse monoclonal antibody specific for DR3.
    J Exp Med. 1982 Jul 1;156(1):104-11 PMID: 6177816
Article Info
Journal
Proceedings of the National Academy of Sciences of the United States of America
Abbr.
Proc Natl Acad Sci U S A
ISSN
0027-8424
Published
1997-05-27
Pages
5772-7
Language
English
Region
United States
NLM ID
7505876
PMCID
PMC20855
Subset
IM
Analysis Services
Analysis Services

Contact

No. 2 Wenbo Road, Zhangqiu District, Jinan, Shandong

Qilu Normal University · Genelibs Bioinformatics Lab

750 Shunhua Rd, Jinan

2F, Bldg F, University Science Park

Tel: 0531-88819269

WeChat Official Account

Follow our WeChat subscription account for real-time updates and the latest in medical and biological research.


Business Email

E-mail: [email protected]